TY - JOUR
T1 - Lack of association between chronological age and fisher group and poor outcomes in older patients with severe-grade aneurysmal subarachnoid hemorrhage
T2 - a nationwide registry study in Japan
AU - Suzuki, Kaima
AU - Sato, Hiroki
AU - Sorimachi, Takatoshi
AU - Fukuda, Hitoshi
AU - Ueba, Tetsuya
AU - Chin, Masaki
AU - Nakatomi, Hirofumi
AU - Shiokawa, Yoshiaki
AU - Ishikawa, Tatsuya
AU - Kawamata, Takakazu
AU - Nakahara, Ichiro
AU - Shimamura, Norihito
AU - Ohkuma, Hiroki
AU - Ichihara, Nao
AU - Kakizaki, Shota
AU - Murayama, Yuichi
AU - Toyoda, Kazunori
AU - Kurita, Hiroki
AU - Ikawa, Fusao
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Older age and Fisher group scores predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). However, among aging societies, treatment indications and decisions in older patients with severe-grade aSAH (World Federation of Neurosurgical Societies [WFNS] grade IV or V) remain poorly understood. Therefore, we aimed to identify the risk factors associated with poor outcomes in non-older and older patients with severe-grade aSAH. We analyzed a database of patients with aSAH treated between April 2007 and December 2019 in Japan and divided them into either the non-older (< 75 years) or older group (age ≥ 75 years) to identify factors associated with poor outcomes (modified Rankin Scale score [mRS] 3–6) at discharge. The data analyzed included patient demographics, comorbidities, aneurysm characteristics, Fisher group, WFNS grade, treatment method, and mRS score at discharge. Among the 5,095 patients, 1,303 (986 non-older and 317 older) were classified as having severe-grade aSAH. In non-older patients, chronological age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.03–1.05) and Fisher groups 3 and 4 were associated with poor outcomes as compared with Fisher group 1 + 2 (OR, 2.98; 95% CI, 1.59–5.58 and OR, 5.49; 95% CI, 2.86–10.54, respectively). However, chronological age and Fisher groups 3 and 4 were not associated with poor outcomes in older patients with severe-grade aSAH. This study suggests that outcomes in older patients with severe-grade aSAH cannot be predicted in the same manner as in non-older patients. Further research on potential prognostic factors, such as biological age, is warranted. Clinical trial number Not applicable.
AB - Older age and Fisher group scores predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). However, among aging societies, treatment indications and decisions in older patients with severe-grade aSAH (World Federation of Neurosurgical Societies [WFNS] grade IV or V) remain poorly understood. Therefore, we aimed to identify the risk factors associated with poor outcomes in non-older and older patients with severe-grade aSAH. We analyzed a database of patients with aSAH treated between April 2007 and December 2019 in Japan and divided them into either the non-older (< 75 years) or older group (age ≥ 75 years) to identify factors associated with poor outcomes (modified Rankin Scale score [mRS] 3–6) at discharge. The data analyzed included patient demographics, comorbidities, aneurysm characteristics, Fisher group, WFNS grade, treatment method, and mRS score at discharge. Among the 5,095 patients, 1,303 (986 non-older and 317 older) were classified as having severe-grade aSAH. In non-older patients, chronological age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.03–1.05) and Fisher groups 3 and 4 were associated with poor outcomes as compared with Fisher group 1 + 2 (OR, 2.98; 95% CI, 1.59–5.58 and OR, 5.49; 95% CI, 2.86–10.54, respectively). However, chronological age and Fisher groups 3 and 4 were not associated with poor outcomes in older patients with severe-grade aSAH. This study suggests that outcomes in older patients with severe-grade aSAH cannot be predicted in the same manner as in non-older patients. Further research on potential prognostic factors, such as biological age, is warranted. Clinical trial number Not applicable.
KW - Aneurysm rupture
KW - Aneurysmal subarachnoid hemorrhage
KW - Chronological age
KW - Fisher group
KW - Hypertension
KW - Older
UR - https://www.scopus.com/pages/publications/105006935580
UR - https://www.scopus.com/pages/publications/105006935580#tab=citedBy
U2 - 10.1007/s10143-025-03638-3
DO - 10.1007/s10143-025-03638-3
M3 - Article
C2 - 40445438
AN - SCOPUS:105006935580
SN - 0344-5607
VL - 48
JO - Neurosurgical Review
JF - Neurosurgical Review
IS - 1
M1 - 466
ER -